[Vogt-Koyanagi-Harada syndrome]

Area of Science:

• Ophthalmology
• Immunology
• Neurology

Background:

• Vogt-Koyanagi-Harada (VKH) syndrome is a rare, idiopathic, multisystemic inflammatory disorder.
• It primarily affects organs rich in melanocytes, including the eyes, central nervous system, and auditory/vestibular systems.
• Early diagnosis is critical due to the potential for severe visual impairment and neurological complications.

Observation:

• The case study details a patient presenting with decreased visual acuity and headaches.
• Diagnostic workup confirmed Vogt-Koyanagi-Harada syndrome.
• This highlights the importance of considering VKH in patients with these non-specific symptoms.

Findings:

• Vogt-Koyanagi-Harada syndrome involves inflammation targeting melanocyte-rich tissues.
• Ocular manifestations such as uveitis, choroiditis, and optic neuritis can lead to significant vision loss.
• Neurological symptoms like headache, meningitis, and cranial nerve palsies are also characteristic.

Implications:

• Timely administration of corticosteroid therapy is essential to prevent irreversible vision loss and neurological damage.
• Increased awareness among clinicians is necessary for prompt recognition and management of VKH syndrome.
• This case and literature review underscore the need for a multidisciplinary approach in managing this complex condition.